Stockscreener 앱 받기
29.48
1.39%
0.405
시장 영업 전:
29.51
0.035
+0.12%
전일 마감가:
$29.07
열려 있는:
$29
하루 거래량:
494.55K
Relative Volume:
0.31
시가총액:
$4.36B
수익:
-
순이익/손실:
$-151.09M
주가수익비율:
-18.89
EPS:
-1.56
순현금흐름:
$-160.51M
1주 성능:
+1.71%
1개월 성능:
+24.16%
6개월 성능:
+135.24%
1년 성능:
+71.77%
1일 변동 폭
$28.52
$29.74
1주일 범위
$28.19
$29.77
52주 변동 폭
$9.60
$29.99
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
CNTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
29.48 | 4.30B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-08-29 | 재개 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-05-08 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
B. Riley Research Analysts Raise Earnings Estimates for CNTA - MarketBeat
OMERS ADMINISTRATION Corp Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
B. Riley Analysts Boost Earnings Estimates for CNTA - Defense World
Centessa Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:CNTA) - MarketBeat
Healthy Upside Potential: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Milestone Pharmaceuticals Inc (MIST) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Grupo Supervielle S.A. ADR (SUPV) looking to reclaim success with recent performance - Setenews
The growth track for Tron Inc (TRON) has changed recently - Setenews
Taking the lead: Argo Blockchain Plc ADR (ARBK) - Setenews
Check out these key findings about Polestar Automotive Holding UK PLC ADR (PSNY) - Setenews
There is no way Rezolve AI PLC (RZLV) can keep these numbers up - Setenews
Check out these key findings about Nova Minerals Limited ADR (NVA) - Setenews
Check Out INVO Fertility Inc (IVF)’s Trade Data Rather Than the Analysts’ Views - Setenews
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Stocks of Klarna Group plc (KLAR) are poised to climb above their peers - Setenews
Its Stock Has Paid Off Big Time For Aptera Motors Corp - Setenews
It makes sense and dollars to buy ATA Creativity Global ADR (AACG) stock - Setenews
Check out these key findings about Hub Cyber Security Ltd (HUBC) - Setenews
A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Investors in cash trouble should check out Bonk Inc (BNKK) - Setenews
Brokers Set Expectations for CNTA FY2025 Earnings - Defense World
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD - Investing.com
CNTA: Phase 2 data show best-in-class efficacy and safety for orexin agonists in sleep disorders - TradingView
The time has not yet come to remove your chips from the table: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Campbell & CO Investment Adviser LLC Acquires New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - The Motley Fool
Centessa Pharma chief technology officer sells $1.04 million in shares By Investing.com - Investing.com India
Centessa Pharma chief technology officer sells $1.04 million in shares - Investing.com
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program - Finviz
Top investors say Vistra Corp (VST) ticks everything they need - setenews.com
[8-K] Centessa Pharmaceuticals plc Reports Material Event | CNTA SEC FilingForm 8-K - Stock Titan
[424B5] Centessa Pharmaceuticals plc Prospectus Supplement (Debt Securities) - Stock Titan
How does Xunlei Ltd ADR (XNET) change from a tortoise to a hare? - Setenews
AMD, Palantir among market cap stock movers on Wednesday By Investing.com - Investing.com UK
Centessa Pharmaceuticals stock hits 52-week high at $25.44 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals stock hits 52-week high at $25.44 - Investing.com
Centessa prices public offering of 11.6 million ADSs at $21.50 each By Investing.com - Investing.com South Africa
Centessa prices public offering of 11.6 million ADSs at $21.50 each - Investing.com India
Centessa Pharmaceuticals stock falls after announcing public offering - Investing.com
Centessa Pharmaceuticals stock falls after announcing public offering By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals launches public offering of ADSs By Investing.com - Investing.com India
Centessa Pharmaceuticals launches public offering of ADSs - Investing.com
Endava PLC Sponsored ADR (DAVA) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance
What is Leerink Partnrs’ Estimate for CNTA FY2025 Earnings? - Defense World
Centessa Pharmaceuticals plc ADR (CNTA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
A Look at SRX Health Solutions Inc (SRXH) Shares in the Recent Past Indicates Growth - Setenews
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Down Following Weak Earnings - Defense World
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):